Literature DB >> 15694382

p53 prevents maturation of T cell development to the immature CD4-CD8+ stage in Bcl11b-/- mice.

K Okazuka1, Y Wakabayashi, M Kashihara, J Inoue, T Sato, M Yokoyama, S Aizawa, Y Aizawa, Y Mishima, R Kominami.   

Abstract

Signaling pathways such as the pre-TCR and Wnt pathways regulate alpha/beta T cell differentiation in thymus. Mice lacking an essential component of the pre-TCR exhibit arrest at the (CD4(-)CD8(-)) (CD44(-)CD25(+)) stage (DN3) of thymocyte development, and introduction of p53 deficiency into those mice abrogates this arrest, resulting in transition to the (CD4(+)CD8(+)) double-positive (DP) stage. This paper examines the effect of inactivation of p53 on thymocyte development in Bcl11b(-/-) mice that exhibit arrest at the DN3 or (CD4(-)CD8(+)) immature single-positive (ISP) stage. No DP thymocytes were detected in thymocytes of adoptive transfer experiments in scid mice that were derived from p53(-/-)Bcl11b(-/-) precursors but ISP thymocytes increased in the proportion and in the cell number approximately three times higher than those from Bcl11b(-/-) precursors. Consistently, the level of apoptosis decreased to the level of wild-type precursors. These results suggest that inactivation of p53 is sufficient for DN3 thymocytes to differentiate into the ISP, but not to DP, stage of thymocyte development in Bcl11b(-/-) mice. This provides evidence for a novel p53-mediated checkpoint that regulates the transition from the DN3 to ISP stage of thymocyte development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694382     DOI: 10.1016/j.bbrc.2005.01.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  miR-34a and miR-125b are upregulated in peripheral blood mononuclear cells from patients with type 2 diabetes mellitus.

Authors:  Yanxin Shen; Huiling Xu; Xiaoyuan Pan; Weijiang Wu; Hui Wang; Linlin Yan; Miaomiao Zhang; Xia Liu; Sheng Xia; Qixiang Shao
Journal:  Exp Ther Med       Date:  2017-10-03       Impact factor: 2.447

Review 2.  Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease.

Authors:  Pravin Kesarwani; Anuradha K Murali; Amir A Al-Khami; Shikhar Mehrotra
Journal:  Antioxid Redox Signal       Date:  2012-10-15       Impact factor: 8.401

3.  A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.

Authors:  Katherine Bessette; Mark L Lang; Roy A Fava; Martin Grundy; Jennifer Heinen; Laurie Horne; Rosanne Spolski; Amin Al-Shami; Herbert C Morse; Warren J Leonard; John A Kelly
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

Review 4.  Role of the transcription factor Bcl11b in development and lymphomagenesis.

Authors:  Ryo Kominami
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

Review 5.  Using mouse models to study function of transcriptional factors in T cell development.

Authors:  Peng Li; Yiren Xiao; Zhixin Liu; Pentao Liu
Journal:  Cell Regen (Lond)       Date:  2012-10-10

6.  Identification of BCL11B as a regulator of adipogenesis.

Authors:  Jun Inoue; Yusuke Ihara; Daisuke Tsukamoto; Keisuke Yasumoto; Tsutomu Hashidume; Kenya Kamimura; Yuji Nakai; Shigeki Hirano; Makoto Shimizu; Ryo Kominami; Ryuichiro Sato
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

Review 7.  Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease.

Authors:  Matthew J Lennon; Simon P Jones; Michael D Lovelace; Gilles J Guillemin; Bruce J Brew
Journal:  Front Cell Neurosci       Date:  2017-03-29       Impact factor: 5.505

Review 8.  Signaling networks controlling ID and E protein activity in T cell differentiation and function.

Authors:  Sung-Min Hwang; Sin-Hyeog Im; Dipayan Rudra
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

Review 9.  Immunological considerations of modern animal models of malignant primary brain tumors.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Martin J Rutkowski; Shanna Fang; C David James; Andrew T Parsa
Journal:  J Transl Med       Date:  2009-10-08       Impact factor: 5.531

10.  Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development.

Authors:  Martina Panattoni; Francesca Sanvito; Veronica Basso; Claudio Doglioni; Giulia Casorati; Eugenio Montini; Jeffrey R Bender; Anna Mondino; Ruggero Pardi
Journal:  J Exp Med       Date:  2008-02-11       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.